Health and human rights crisis imminent
for opiate substitution therapy clients in the Crimea
- Russian troops are blocking vital supplies for drug users.
” Since highways into Crimea are blocked by armed men, medicines supply is impossible (narcotic drugs must be attended by an armed police squad).” — Alliance Ukraine
As has been widely reported, the Crimean peninsula, previously an autonomous region of Ukraine has been unilaterally annexed by the Russian Federation in defiance of international law. The aspect of this crisis that most concerns us is the situation that will be faced by the more than eight hundred clients of Crimean opiate substitution programmes should the region become subject to the current legislative framework of the Russian Federation which includes the outlawing of opiate substitution therapy.
Indeed, on 20th March 2014, Mr. Ivanov, the head of the Russian Federal Drug Control Service, the ministry responsible for drug policy in the Russian Federation announced his intention to close the opiate substitution therapy programmes as his first priority.
Bangkok, Thailand, February 28, 2014 –Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB)
AIDS activists, including people living with HIV, people living with HCV, people who inject drugs (PWID), and their allies, are fighting for access to a new generation of HCV drugs-called direct-acting antivirals (DAAs). These drugs offer the potential to eradicate HCV; they have cured up to 100 percent of people in clinical trials.
All of the companies refused to commit to price reductions that would allow affordable access for low- and middle-income countries (LMICs), home to more than 85 percent of the 185 million people living with HCV. Even Roche and Merck, producers of older, soon-to-be-obsolete HCV drugs, refused to lower prices to affordable levels.
In high-income countries, DAA treatment costs US$140,000, although DAAs are cheap to produce. According to an analysis by academic experts, it costs less than US$250 for a 12-week DAA regimen. “This level of greed is inexcusable, and keeps the cure out of reach for almost everyone who needs these drugs,” says Shiba Phurailatpam, regional coordinator of the Asia Pacific Network of People Living with HIV/AIDS (APN+).
“Too cool to do drugs” pencils withdrawn
This is an oldie, but definately a goodie..
A company recalled a batch of pencils after a fourth-grade student pointed out an embarrassing message that appeared after he sharpened his pencil.
The pencils carried the slogan ”Too Cool to Do Drugs.” But the student noticed that when the pencils are sharpened and get shorter, the message becomes ”Cool to Do Drugs,” then simply ”Do Drugs.”
Meth Mouth and Other Meth Myths
The Hepatitis C Treatment Outcome Study
Please consider taking part in The Hepatitis C Treatment Outcome Study being conducted at Bond University that will support work that may benefit people whose lives are affected by viral hepatitis.
The study is open to individuals preparing for hepatitis C treatment and participants are being sought from Australia or New Zealand. Information provided is completely confidential and you have the right to withdraw from the study at any time.
HRV at the Victorian Gay & Lesbian Pride March 2014
Bloody Serious Facts!